$10,000+ CalVaxGrant Available to Approved Small Practices in California for COVID-19 Vaccination Assistance
July 15, 2021 – The California Department of Public Health (CDPH) announced recently that small practices approved for providing COVID-19 vaccinations can apply to request a CalVaxGrant of $10,000, and an additional $1,000 per additional site, if their vaccination sites serve high priority areas. The CalVaxGrant is funded by the California Department of Public Health (CDPH) and administered by Physicians for a Healthy California (PHC).
The award is intended to reimburse practices up to $55,000 to set up their offices as small, community-based vaccination sites. Allowable expenses include staffing, training, technology, infrastructure, supplies and equipment, and administrative overhead.
To be eligible, practices must meet all the following criteria:
- Have fewer than 200 physicians,
- Completed Section A and B of the myCAvax enrollment process,
- Spent or plan to spend $10,000 per site (up to five sites) between November 1, 2020 and November 1, 2021, and
- Have an unrestricted license and be in good standing with their licensing board.
CalVaxGrant applications may be submitted to the Physicians for a Healthy California from July 12 through August 13, 2021. Visit their website for more details. In addition, we encourage you to register for one of the provider webinars about the CalVaxGrant offered by Physicians for a Healthy California.
- Review the CalVaxGrant’s qualifying high priority areas
- Visit the Physicians for a Health California website;
- Register for a provider webinar conducted by Physicians for a Healthy California:
IPA/medical groups financially responsible for COVID-19 testing costs for HMO commercial plan members, effective August 1, 2021
June 22, 2021 – Effective for dates of service on and after August 1, 2021, all COVID-19 testing costs for Blue Shield of California HMO commercial plan members will become the financial responsibility of the member’s HMO IPA/medical group, consistent with each group’s existing contract with Blue Shield. This requirement follows the recent ruling by the Los Angeles County Superior Court on May 5, 2021 which invalidated aspects of the DMHC’s emergency regulation on COVID-19 testing that required plans to assume financial responsibility for those costs. In addition, the remaining provisions of the DMHC’s emergency regulation have expired.
Blue Shield will be notifying contracted laboratories of this change, and requests that IPA/medical groups notify labs to send claims for COVID-19 testing services provided on and after August 1, 2021 to the IPA/medical group.
Review updated information (PDF, 74 KB)
COVID-19 vaccine administration and certain monoclonal antibody treatments: cost-sharing, coding, and billing
April 5, 2021- Download our latest update that includes information on the Janssen COVID-19 vaccine, as well as coding and billing for monoclonal antibody treatments.
Review COVID-19 vaccine and monoclonal antibody treatment (PDF, 77 KB)